|
Variable
|
β
|
SE (β)
|
Odds ratio (95% CI)
|
Pvalue
|
|---|
|
In-hospital mortality*
| | | | |
|
Atrial fibrillation
|
0.804
|
0.143
|
2.23 (1.69-2.96)
|
0.000
|
|
Congestive heart failure
|
0.728
|
0.235
|
2.07 (1.31-2.28)
|
0.002
|
|
Chronic obstructive pulmonary disease
|
0.539
|
0.216
|
1.71 (1.12-2.62)
|
0.013
|
|
Age
|
0.047
|
0.008
|
1.05 (1.03-1.06)
|
0.000
|
|
Statin use before stroke
|
-0.568
|
0.234
|
0.57 (0.36-0.89)
|
0.002
|
|
Favourable outcome (mRS grades 0-2)†
| | | | |
|
Statin use before stroke
|
0.274
|
0.139
|
1.32 (1.01-1.73)
|
0.049
|
|
Congestive heart failure
|
-0.926
|
0.353
|
0.40 (0.20-0.79)
|
0.009
|
- * β = -6.029, SE (β) = 0.649, goodness of fit χ2 = 8.929, d.f. = 8, P = 0.348.
-
† β = -1.511, SE (β) = 0.065, goodness of fit χ2 = 0.041, d.f. = 1, P = 0.839.
